Canada markets closed

PharmaTher Holdings Ltd. (PHRM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1300+0.0050 (+4.00%)
At close: 03:30PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 10.94M
Enterprise Value -891.58k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.95
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.26

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-79.84%
S&P500 52-Week Change 3-16.62%
52 Week High 30.7200
52 Week Low 30.1000
50-Day Moving Average 30.1319
200-Day Moving Average 30.1889

Share Statistics

Avg Vol (3 month) 399.75k
Avg Vol (10 day) 390.03k
Shares Outstanding 587.52M
Implied Shares Outstanding 6N/A
Float 871.81M
% Held by Insiders 118.95%
% Held by Institutions 10.06%
Shares Short (Aug 14, 2022) 418.79k
Short Ratio (Aug 14, 2022) 40.23
Short % of Float (Aug 14, 2022) 4N/A
Short % of Shares Outstanding (Aug 14, 2022) 40.02%
Shares Short (prior month Jul 14, 2022) 442.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2022
Most Recent Quarter (mrq)May 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.35%
Return on Equity (ttm)-46.06%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.96M
Net Income Avi to Common (ttm)-4.01M
Diluted EPS (ttm)-0.0530
Quarterly Earnings Growth (yoy)-1.50%

Balance Sheet

Total Cash (mrq)12.12M
Total Cash Per Share (mrq)0.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)36.82
Book Value Per Share (mrq)0.13

Cash Flow Statement

Operating Cash Flow (ttm)-3.51M
Levered Free Cash Flow (ttm)-1.92M